When analyzing distinct markers among LAG-3 + B cells, we observed that most of these cells in the spleen and tDLNs had IgD expression for both control and tumor-bearing mice, accounting for ≥ 90% of CD19 + LAG-3 + cells (Fig. 4f–g). This evidence concerns the gene CD19 and neoplasm.